Thomas E. Massey

2.5k total citations
75 papers, 2.1k citations indexed

About

Thomas E. Massey is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Thomas E. Massey has authored 75 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 21 papers in Cancer Research and 18 papers in Pharmacology. Recurrent topics in Thomas E. Massey's work include Carcinogens and Genotoxicity Assessment (21 papers), DNA Repair Mechanisms (13 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Thomas E. Massey is often cited by papers focused on Carcinogens and Genotoxicity Assessment (21 papers), DNA Repair Mechanisms (13 papers) and Pharmacogenetics and Drug Metabolism (13 papers). Thomas E. Massey collaborates with scholars based in Canada, United States and Netherlands. Thomas E. Massey's co-authors include Leanne L. Bedard, William J. Racz, Richard K. Stewart, James F. Brien, Will D. King, Robin M. Walker, T. F. McElligott, Ling Liu, Susan P.C. Cole and Douglas W. Loe and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Thomas E. Massey

75 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Massey Canada 26 796 552 435 389 349 75 2.1k
R.K. Bhattacharya India 29 1.0k 1.3× 533 1.0× 397 0.9× 194 0.5× 281 0.8× 101 2.3k
Josef Ozer United States 18 961 1.2× 248 0.4× 150 0.3× 442 1.1× 247 0.7× 27 2.5k
Chithan Kandaswami United States 24 1.2k 1.5× 583 1.1× 301 0.7× 233 0.6× 279 0.8× 44 3.1k
Faith M. Williams United Kingdom 31 460 0.6× 717 1.3× 283 0.7× 563 1.4× 271 0.8× 87 2.8k
T. Colin Campbell United States 27 445 0.6× 570 1.0× 462 1.1× 362 0.9× 180 0.5× 79 2.3k
Maria Russo Italy 30 1.7k 2.1× 413 0.7× 361 0.8× 232 0.6× 365 1.0× 76 3.7k
David E. Amacher United States 27 758 1.0× 240 0.4× 519 1.2× 599 1.5× 266 0.8× 74 2.1k
Nicole H.P. Cnubben Netherlands 29 1.2k 1.6× 327 0.6× 210 0.5× 433 1.1× 581 1.7× 57 3.3k
Robert Domitrović Croatia 28 748 0.9× 370 0.7× 135 0.3× 686 1.8× 186 0.5× 54 2.5k
Donald S. Davies United Kingdom 31 923 1.2× 159 0.3× 359 0.8× 1.3k 3.2× 709 2.0× 92 3.0k

Countries citing papers authored by Thomas E. Massey

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Massey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Massey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Massey more than expected).

Fields of papers citing papers by Thomas E. Massey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Massey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Massey. The network helps show where Thomas E. Massey may publish in the future.

Co-authorship network of co-authors of Thomas E. Massey

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Massey. A scholar is included among the top collaborators of Thomas E. Massey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Massey. Thomas E. Massey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vuuren, Ross D. Jansen‐van, et al.. (2022). Deuterated Drugs and Biomarkers in the COVID-19 Pandemic. ACS Omega. 7(46). 41840–41858. 42 indexed citations
2.
Bondy, Genevieve S., et al.. (2015). The impact of chronic Aflatoxin B1 exposure and p53 genotype on base excision repair in mouse lung and liver. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 773. 63–68. 12 indexed citations
3.
4.
Bondy, Genevieve S., et al.. (2014). Up-regulation of nucleotide excision repair in mouse lung and liver following chronic exposure to aflatoxin B1 and its dependence on p53 genotype. Toxicology and Applied Pharmacology. 275(2). 96–103. 12 indexed citations
5.
Brien, James F., et al.. (2013). Cytotoxic interaction between amiodarone and desethylamiodarone in human peripheral lung epithelial cells. Chemico-Biological Interactions. 204(3). 135–139. 5 indexed citations
6.
Ho, Vikki, Thomas E. Massey, & Will D. King. (2011). Thymidylate synthase gene polymorphisms and markers of DNA methylation capacity. Molecular Genetics and Metabolism. 102(4). 481–487. 8 indexed citations
7.
Ho, Vikki, Thomas E. Massey, & Will D. King. (2010). Influence of thymidylate synthase gene polymorphisms on total plasma homocysteine concentrations. Molecular Genetics and Metabolism. 101(1). 18–24. 7 indexed citations
8.
Brown, Pamela & Thomas E. Massey. (2009). In vivo treatment with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces organ-specific alterations in in vitro repair of DNA pyridyloxobutylation. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 663(1-2). 15–21. 14 indexed citations
9.
Herzog, Christopher R., Brian Pittman, Robert R. Maronpot, et al.. (2004). Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression. Oncogene. 23(17). 3033–3039. 15 indexed citations
10.
Harper, Patricia A., et al.. (2001). Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities. Cancer Epidemiology and Prevention Biomarkers. 10(8). 839–853. 1 indexed citations
11.
Castonguay, André, et al.. (1999). Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells. Carcinogenesis. 20(9). 1809–1818. 20 indexed citations
12.
Loe, Douglas W., Richard K. Stewart, Thomas E. Massey, Roger G. Deeley, & Susan P.C. Cole. (1997). ATP-Dependent Transport of Aflatoxin B1 and Its Glutathione Conjugates by the Product of the Multidrug Resistance Protein (MRP) Gene. Molecular Pharmacology. 51(6). 1034–1041. 163 indexed citations
13.
Stewart, Richard K., Cosette J. Serabjit‐Singh, & Thomas E. Massey. (1996). GlutathioneS-Transferase-Catalyzed Conjugation of Bioactivated Aflatoxin B1in Rabbit Lung and Liver. Toxicology and Applied Pharmacology. 140(2). 499–507. 18 indexed citations
14.
Stewart, Richard K., et al.. (1996). Biotransformation of aflatoxin B1 in human lung. Carcinogenesis. 17(11). 2487–2494. 60 indexed citations
15.
Massey, Thomas E., et al.. (1995). The 1994 Veylien Henderson Award of the Society of Toxicology of Canada. Mechanisms in the pathogenesis of amiodarone-induced pulmonary toxicity. Canadian Journal of Physiology and Pharmacology. 73(12). 1675–1685. 40 indexed citations
16.
17.
Liu, Ling, Kanji Nakatsu, & Thomas E. Massey. (1993). In vitro cytochrome P450 monooxygenase and prostaglandin H-synthase mediated aflatoxin B1 biotransformation in guinea pig tissues: Effects of β-naphthoflavone treatment. Archives of Toxicology. 67(6). 379–385. 13 indexed citations
18.
Matula, T.I., et al.. (1993). DNA binding and mutagenicity of aflatoxin B1 catalyzed by isolated rabbit lung cells. Carcinogenesis. 14(7). 1429–1434. 7 indexed citations
19.
Riddick, David S., Jane E. Mackie, Thomas E. Massey, & Gerald S. Marks. (1990). 3,5-Diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine inactivates rat liver cytochrome P-450c, but not its orthologue, rabbit lung form 6. Canadian Journal of Physiology and Pharmacology. 68(3). 370–373. 4 indexed citations
20.
Massey, Thomas E. & James R. Fouts. (1985). Mixed-function oxidase activity in enriched populations of ciliated cells freshly isolated from rabbit tracheas. Cell Biology and Toxicology. 1(4). 297–308. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.K. Bhattacharya Breakdown of academic impact, for papers by Josef Ozer Breakdown of academic impact, for papers by Chithan Kandaswami Breakdown of academic impact, for papers by Faith M. Williams Breakdown of academic impact, for papers by T. Colin Campbell Breakdown of academic impact, for papers by Maria Russo Breakdown of academic impact, for papers by David E. Amacher Breakdown of academic impact, for papers by Nicole H.P. Cnubben Breakdown of academic impact, for papers by Robert Domitrović Breakdown of academic impact, for papers by Donald S. Davies
Rankless by CCL
2026